Skip to main content

Table 3 Concomitant medications

From: Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study

Concomitant Medication, n (%)

Insomnia With Psychiatric Disorders

Insomnia Without Psychiatric Disorders

Elderly

Nonelderly

Elderly

Nonelderly

(n = 81)

(n = 80)

(n = 83)

(n = 81)

Psychoneurotic

47 (58.0)

52 (65.0)

8 (9.6)

4 (4.9)

Sedative, anxiolytic

31 (38.3)

30 (37.5)

7 (8.4)

3 (3.7)

Antipeptic ulcer

31 (38.3)

19 (23.8)

17 (20.5)

11 (13.6)

Analgesic, antipruritic, astringent, anti-inflammatory

29 (35.8)

15 (18.8)

28 (33.7)

10 (12.3)

Antihyperlipidemic agents

27 (33.3)

5 (6.3)

25 (30.1)

8 (9.9)

Antihypertensive agents

27 (33.3)

1 (1.3)

25 (30.1)

10 (12.3)

Vasodilators

23 (28.4)

3 (3.8)

20 (24.1)

7 (8.6)

Antipyretic, analgesic,anti-inflammatory

21 (25.9)

22 (27.5)

22 (26.5)

21 (25.9)

Cold and cough preparations

10 (12.3)

14 (17.5)

9 (10.8)

6 (7.4)

Other anti-allergy

8 (9.9)

14 (17.5)

10 (12.0)

4 (4.9)

Oriental medicines

18 (22.2)

9 (11.3)

16 (19.3)

8 (9.9)

Expectorant

7 (8.6)

5 (6.3)

13 (15.7)

10 (12.3)

Antitussive

6 (7.4)

6 (7.5)

11 (13.3)

8 (9.9)

Antibioticsa

9 (11.1)

8 (10.0)

9 (10.8)

8 (9.9)

  1. a Acting mainly on gram-positive and gram-negative bacteria.